Original Query: ALL
Previous Study | Return to List | Next Study

Open-Label,Singel Center Study of Alefacept in Patients With Atopic Dermatitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00376129
Recruitment Status : Completed
First Posted : September 14, 2006
Last Update Posted : December 10, 2007
Biogen-Dompé AG
Information provided by:
University Hospital Inselspital, Berne

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : January 2007